# TACROLIMUS
> **ANDA210929** · Abbreviated New Drug Application (Generic) · Sponsor: HANGZHOU ZHONGMEI · Approved 2023-04-17
## Drug
- **FDA Application Number:** ANDA210929
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TACROLIMUS
- **Generic name:** TACROLIMUS
- **Active ingredients:** TACROLIMUS
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HANGZHOU ZHONGMEI
- **Manufacturer:** Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
- **First approval:** 2023-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210929)
---
*MORVS · CC0 1.0*